WO2003037358A1 - A pharmaceutical composition having cholagogic and litholytic effect and its preparation method - Google Patents
A pharmaceutical composition having cholagogic and litholytic effect and its preparation method Download PDFInfo
- Publication number
- WO2003037358A1 WO2003037358A1 PCT/CN2002/000622 CN0200622W WO03037358A1 WO 2003037358 A1 WO2003037358 A1 WO 2003037358A1 CN 0200622 W CN0200622 W CN 0200622W WO 03037358 A1 WO03037358 A1 WO 03037358A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- present
- pharmaceutical composition
- cholagogic
- preparation
- quality control
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
- A61K36/315—Isatis, e.g. Dyer's woad
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Mycology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Alternative & Traditional Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/494,143 US20050042308A1 (en) | 2001-10-29 | 2002-09-05 | Pharmaceutical composition having cholagogic and litholytic effect and its preparation method |
| JP2003539701A JP4593918B2 (ja) | 2001-10-29 | 2002-09-05 | 胆汁分泌促進、結石溶解作用を有する一種の薬物組成物、及びその製造方法 |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN01134090.8 | 2001-10-29 | ||
| CNB011340908A CN1179735C (zh) | 2001-10-29 | 2001-10-29 | 一种治疗肝胆结石的溶石性药物及制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2003037358A1 true WO2003037358A1 (en) | 2003-05-08 |
Family
ID=4672224
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/CN2002/000622 Ceased WO2003037358A1 (en) | 2001-10-29 | 2002-09-05 | A pharmaceutical composition having cholagogic and litholytic effect and its preparation method |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20050042308A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP4593918B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN1179735C (cg-RX-API-DMAC7.html) |
| WO (1) | WO2003037358A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102210742B (zh) * | 2010-04-09 | 2013-06-05 | 四川济生堂药业有限公司 | 薄荷素油在制备治疗胆汁淤积性肝病的药物中的应用 |
| CN112516213B (zh) * | 2020-12-30 | 2022-06-17 | 广西中医药大学 | 一种治疗胆结石的瑶药组合物、汤剂、胶囊剂及其应用 |
| CN113421620B (zh) * | 2021-05-17 | 2025-04-29 | 陕西中医药大学 | 基于uplc-q-tof/mse和整合效应的bp神经网络关联分析对中药不同功效的生物活性成分进行模糊识别的方法 |
| CN113624707B (zh) * | 2021-09-17 | 2024-06-18 | 云南博瑞生物科技有限公司 | 一种萝卜红气味定量检测方法 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1060964A (zh) * | 1990-10-29 | 1992-05-13 | 洛洪程 | 一种热伤药物的制取方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60172925A (ja) * | 1984-02-17 | 1985-09-06 | Kao Corp | 胆石溶解剤 |
| JPH0757734B2 (ja) * | 1990-10-09 | 1995-06-21 | 呉羽化学工業株式会社 | 鎮静用香料組成物および香粧品 |
| DE4330664A1 (de) * | 1993-09-10 | 1995-03-16 | Beiersdorf Ag | Verwendungen von Pflanzenölen |
| JPH07242536A (ja) * | 1994-03-01 | 1995-09-19 | Toyo Capsule Kk | 皮膜に精油成分が含有されたゼラチンカプセル剤 |
| JP3828163B2 (ja) * | 1994-06-10 | 2006-10-04 | サンスター株式会社 | 抗炎症、抗かゆみ剤 |
| EP0842604A1 (en) * | 1996-11-13 | 1998-05-20 | The Procter & Gamble Company | Sprayable disinfecting compositions and processes for disinfecting surfaces therewith |
| IL129102A0 (en) * | 1999-03-22 | 2000-02-17 | J P M E D Ltd | An emulsion |
| EP1146112A1 (en) * | 2000-04-14 | 2001-10-17 | The Procter & Gamble Company | Process of cleaning and/or disinfecting a hard surface with a composition comprising a biguanide antimicrobial agent |
-
2001
- 2001-10-29 CN CNB011340908A patent/CN1179735C/zh not_active Expired - Lifetime
-
2002
- 2002-09-05 WO PCT/CN2002/000622 patent/WO2003037358A1/zh not_active Ceased
- 2002-09-05 US US10/494,143 patent/US20050042308A1/en not_active Abandoned
- 2002-09-05 JP JP2003539701A patent/JP4593918B2/ja not_active Expired - Lifetime
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1060964A (zh) * | 1990-10-29 | 1992-05-13 | 洛洪程 | 一种热伤药物的制取方法 |
Non-Patent Citations (1)
| Title |
|---|
| LI XINREN ET AL.: "Inhibitory effect of the oil distilled from pelargonium graveolens L' herit on aldrin-induced overgrowth of lens of chicken embyoeye", CANCER, vol. 13, no. 3, 1994, pages 203 - 205 * |
Also Published As
| Publication number | Publication date |
|---|---|
| JP4593918B2 (ja) | 2010-12-08 |
| CN1358530A (zh) | 2002-07-17 |
| CN1179735C (zh) | 2004-12-15 |
| US20050042308A1 (en) | 2005-02-24 |
| JP2005514343A (ja) | 2005-05-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI271198B (en) | Tables disintegrating rapidly in the oral cavity | |
| CA2339991A1 (en) | Microemulsions as solid dosage forms for oral administration | |
| WO2004016244A3 (en) | Pharmaceutical compositions for buccal delivery of pain relief medications | |
| WO2002058698A3 (en) | Malonyl-coa decarboxylase inhibitors useful as metabolic modulators | |
| WO2002017855A3 (en) | Process for preparing pharmaceutical compositions for use with soft gelatin formulations | |
| SG155046A1 (en) | Process for modifying drug crystal formation | |
| WO2003026610A3 (en) | Process for the preparation of fast dissolving dosage form | |
| WO2001080619A3 (en) | Pharmaceutical composition containing citalopram | |
| WO2001097805A3 (en) | Solid valsartan pharmaceutical compositions | |
| WO2007134158A3 (en) | Granules comprising calcium carbonate, a binder and a porosity increasing agent, processes of manufacturing, use in therapy | |
| CA2467676A1 (en) | Use of glutamate, glutamate derivatives or metabolites, glutamate analogues or mixtures thereof for the manufacture of a composition for the treatment of osteoporosis | |
| MY137846A (en) | Processes for the preparation of oral dosage formulations of modafinil | |
| WO2005107721A3 (en) | Pharmaceutical dosage form comprising pellets as well as its manufacturing process | |
| KR910005854A (ko) | 캡슐 경구 투여 단위 형태의 구형 과립으로부터 조절된 방출 탄산 탈수 효소 저해제를 함유하는 제약학적 조성물 및 그 제조방법 | |
| WO2002060435A8 (fr) | Cryptotanshinone permettant de prevenir et d'attenuer la maladie d'alzheimer | |
| CA2483002A1 (en) | New pharmaceutical composition | |
| WO2004087880A3 (en) | Compounds and their use to treat diabetes and related disorders | |
| TW202038920A (zh) | 發泡性經口固形製劑 | |
| AU2366501A (en) | Pharmaceutical composition comprised of spider venoms, the production thereof, and its use for treating tumor diseases | |
| CA2166460A1 (en) | Neomorphic ibuprofen and methods of using same | |
| MD2722B2 (ro) | Compoziţie farmaceutică cu carbonat de calciu sau amestecul lui cu hidroxicarbonat de magneziu sau cu vitamina D, utilizată pentru profilaxia sau tratamentul osteoporozei | |
| EP2101742B8 (en) | Pharmaceutical composition containing clopidogrel hydrogenesulphate of polymorph 1 form | |
| WO2004078108A3 (fr) | Comprime de fenofibrate et procede de fabrication | |
| JP6771274B2 (ja) | 内服用組成物 | |
| EP4438121A3 (en) | Pharmaceutical composition containing acetominophen and ibuprofen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| WWE | Wipo information: entry into national phase |
Ref document number: 2003539701 Country of ref document: JP |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 10494143 Country of ref document: US |
|
| 122 | Ep: pct application non-entry in european phase |